spacer
home > pmps > autumn 2008 > turbocor chillers come of age
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Turbocor Chillers Come of Age

When Turbocor compressor chillers were launched a few years ago, they were very well received, as they offer pharmaceutical companies a highly efficient chiller that can significantly cut both carbon emissions and fuel costs. Their introduction was timely, with pharmaceutical companies having to weigh up their air conditioning choices with increasing pressure from rising energy prices as well as EU regulations, including the F-Gas Regulation, and a raft of building legislation introduced by the Government to reduce carbon output, in line with Kyoto targets.

However, these Turbocor compressors were a huge technological leap, so it was not surprising that the technology took time to overcome teething problems as the industry familiarised itself with the product. Turbocor compressors brought huge efficiency savings, but the innovative design was so dramatically different from previous compressors that it took time to produce the optimum relationship between chiller and compressor. However, this refining process has now resulted in proven chiller technology that offers all the efficiencies that the prototype compressor promised, therefore providing pharmaceutical companies with a reliable and highly efficient air conditioning solution for comfort cooling in manufacturing, clean room and office applications.

ADVANTAGES OF THE NEW CHILLERS

So why should pharmaceutical companies opt for Turbocor technology? For the pharmaceutical sector, having a Turbocor compressor at the heart of a chiller means a company can depend on its simple design, which incorporates just one moving part, to increase the reliability of the equipment and help avoid unscheduled system outages.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Steve Warnock is Managing Director of the specialist industrial water chiller and cooling systems Coolmation Group. He has over 35 years of experience in the mechanical and engineering industry, beginning his career with the Army and Navy where he spent 15 years. On leaving the Armed Forces, Steve progressed up to Senior Operating Director in a service to business operation, Norland Managed Services. He joined Coolmation in 2006 as Group Managing Director.
spacer
Steve Warnock
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Surge of Indian biosimilars market forecast in 2019

16th April 2019: New data from CPhI shows that, despite ongoing reputational challenges, India’s biologics market is set for robust growth in 2019 driven by biosimilars production. The India specific findings from CPhI’s bio league tables predict strong ‘bio growth potential’ in India throughout 2019 in the build-up to the 13th edition of CPhI India 2019, which will take place at the India Expo Centre in Delhi NCR.
More info >>

White Papers

Preparation of Pharmaceutical Samples for Metals Analysis

RSSL

There has been a lot of discussion regarding the methods of analysis for pharmaceutical products as we await the upcoming changes to both the EP and USP, relating to the analysis of metal impurities.
More info >>

 
Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement